Article ID Journal Published Year Pages File Type
5546586 Acta Pharmaceutica Sinica B 2017 11 Pages PDF
Abstract
AMP-activated protein kinase (AMPK) has been identified as an attractive therapeutic target for cancer, type 2 diabetes, atherosclerosis, myocardial ischemia/reperfusion injury and neurodegenerative disease. This review summarizes and updates the paradoxical role of AMPK implicated in these human diseases and put forward the challenge encountered.326
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Drug Discovery
Authors
, , , ,